Day: November 18, 2022

SCOTTSDALE, Ariz., Nov. 18, 2022 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, today announced that the holders of record of the Company’s 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) as of the close of business on November 30, 2022 will receive a cash dividend equal to $ 0.5529514 per Series A Preferred Stock share. The cash dividend will be paid on December 15, 2022. About AMMO, Inc. With its corporate offices headquartered in Scottsdale, Arizona, AMMO designs and manufactures products for a variety of aptitudes, including law enforcement, military,...

The Company will provide an update regarding the distribution date Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that on November 13, 2022, the Tel Aviv District Court Economic Department approved the Company’s motion for the approval of a cash capital distribution of up to $1.6 million. The approval by the Israeli court is in effect for 180 days. Following the approval of the Israeli court, Medigus’ board of directors resolved on November 17, 2022 to make a cash capital distribution of $1.6 million which will be paid to the holders of the Company’s ADSs and eligible warrant holders in proportion to their respective holdings. A separate announcement...

ROCKAWAY, N.J., Nov. 18, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore Sapphire has been issued a National Code Number (CNK) in Belgium.  CNK numbers are unique product code identifiers allocated by the Belgian Pharmaceutical Association (APB) for products and medicines commercially available from pharmacies throughout Belgium and enables product recognition throughout the pharmaceutical network.  “This positive news will allow us to provide patients with a convenient way to easily access gammaCore at their local pharmacy,” mentioned Iain Strickland, Senior Vice President Global Sales and Strategy at electroCore. “We have taken a big step forward in making our therapy more widely available throughout Europe. The publication...

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended as an early intervention to slow disease progression in patients affected with Stargardt Disease (STGD1) and Dry Age-related Macular Degeneration (Dry AMD) There are currently no approved treatments for STGD1 and Dry AMD Currently, a 2-year Phase 2 study in adolescent STGD1 patients is ongoing and a global Phase 3 study in adolescent STGD1 patients (the “DRAGON” study) is recruiting subjects 12-month interim data from the ongoing Phase 2 STGD1 study continues to show halting or slowing of lesion growth Tinlarebant has been granted Fast Track Designation and Rare Pediatric Disease Designation in the U.S., and Orphan Drug Designation in both the U.S. and Europe for STGD1SAN DIEGO, Nov. 18, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a San...

FORT WORTH, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has priced a $10.675 million underwritten offering of 9,282,609 shares of its common stock and warrants to purchase up to 4,641,305 shares of common stock. The warrants are being sold at the rate of one warrant for every two shares of common stock. The public offering price, before the underwriters’ discount and commissions, for each share of common stock and accompanying warrant is $1.15. All of the securities in the offering were sold by the TFF Pharmaceuticals, Inc. In addition, the Company has granted the underwriters a 45-day option...

TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) — VVC Exploration Corporation, dba VVC Resources, (“VVC” or the “Company“) announces the following: Warrant Exercises From October 1 to November 17, 2022, the Company received gross proceeds of $1.5 million pursuant to the exercise of Series AE and AA warrants. Shareholders holding Series AA warrants are reminded that these warrants expire on November 30, 2022. Stockhouse Publishing Pursuant to an arrangement with Stockhouse Publishing Ltd. in 2021, VVC is settling $15,000 of indebtedness by the issuance of 214,285 shares at the price of $0.07. The Securities to be issued pursuant to this transaction will be subject to the approval of the TSX Venture Exchange and to the applicable statutory, exchange and regulatory hold period of four months and any other required...

The Event Technology Awards are celebrating their tenth anniversary and recognise the achievements of companies delivering digital and technological solutions to the events industry. VANCOUVER, B.C., Nov. 18, 2022 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce that their digital ticketing solution CheckPoint has won the award for best Ticketing Technology at the 2022 Event Technology Awards. The Event Technology Awards, which are now running for their tenth year, recognise the achievements of companies delivering digital and technological solutions to the events industry. They are very coveted and well-renowned awards that have been won by...